{
    "clinical_study": {
        "@rank": "70405", 
        "arm_group": [
            {
                "arm_group_label": "ceftazidime+ciprofloxacin", 
                "arm_group_type": "Experimental", 
                "description": "2 synergistic antibiotics(ceftazidime IP and ciprofloxacin po for gram negative bacterial peritonitis)"
            }, 
            {
                "arm_group_label": "ceftazidime monotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "ceftazidime IP for  gram negative bacterial peritonitis"
            }, 
            {
                "arm_group_label": "cefazolin+gentamicin", 
                "arm_group_type": "Experimental", 
                "description": "cefazolin IP and gentamicin IP for gram positive bacterial peritonitis"
            }, 
            {
                "arm_group_label": "cefazolin monotherapy", 
                "arm_group_type": "Active Comparator", 
                "description": "cefazolin IP for gram positive bacterial peritonitis"
            }
        ], 
        "brief_summary": {
            "textblock": "To compare the efficacy of single versus combined antibiotic therapy for bacterial\n      peritonitis in CAPD patients."
        }, 
        "brief_title": "Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in CAPD Patients", 
        "completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "condition": "Peritonitis", 
        "condition_browse": {
            "mesh_term": "Peritonitis"
        }, 
        "detailed_description": {
            "textblock": "To compare relapse and recurrent rate of peritonitis between single and combined antibiotic\n      regimens for bacterial peritonitis in CAPD patients."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  age >/= 18 years old\n\n          -  ESRD patients on continuous ambulatory peritoneal dialysis more than 4 weeks\n\n          -  presence of symptom or sign of peritonitis\n\n          -  presence of WBC >100cell/mm3 with PMN >50% in peritoneal dialysate or gram stain\n             positive for gram positive or gram negative bacteria\n\n        Exclusion Criteria:\n\n          -  presence of polymicrobial organism, non-fermentative gram negative organism, fungus,\n             mycobacteria in peritoneal fluid or culture-negative\n\n          -  peritonitis from the organisms that required combined antibiotic therapy according to\n             ISPD guideline 2010\n\n          -  hospital-acquired peritonitis\n\n          -  presence of catheter-related infection\n\n          -  history of peritonitis within 4 weeks\n\n          -  currently taking antibiotic\n\n          -  allergic to the antibiotic that used in the study(penicillin or cephalosporin or\n             quinolone or aminoglycoside)"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "75 Years", 
            "minimum_age": "15 Years"
        }, 
        "enrollment": {
            "#text": "300", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "January 30, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01785641", 
            "org_study_id": "RA56/006"
        }, 
        "intervention": [
            {
                "arm_group_label": "ceftazidime+ciprofloxacin", 
                "description": "2 synergistic antibiotics: ceftazidime IP + ciprofloxacin po for gram negative bacterial peritonitis", 
                "intervention_name": "ceftazidime+ciprofloxacin", 
                "intervention_type": "Drug", 
                "other_name": "combined antibiotic therapy"
            }, 
            {
                "arm_group_label": "ceftazidime monotherapy", 
                "description": "ceftazidime IP for gram negative bacterial peritonitis", 
                "intervention_name": "ceftazidime monotherapy", 
                "intervention_type": "Drug", 
                "other_name": "monotherapy"
            }, 
            {
                "arm_group_label": "cefazolin+gentamicin", 
                "description": "cefazolin IP + gentamicin IP for gram positive bacterial peritonitis", 
                "intervention_name": "cefazolin+gentamicin", 
                "intervention_type": "Drug", 
                "other_name": "combined antibiotic therapy"
            }, 
            {
                "arm_group_label": "cefazolin monotherapy", 
                "description": "cefazolin IP for gram positive bacterial peritonitis", 
                "intervention_name": "cefazolin monotherapy", 
                "intervention_type": "Drug", 
                "other_name": "monotherapy"
            }
        ], 
        "intervention_browse": {
            "mesh_term": [
                "Anti-Bacterial Agents", 
                "Cefazolin", 
                "Ceftazidime", 
                "Gentamicins", 
                "Antibiotics, Antitubercular", 
                "Ciprofloxacin"
            ]
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "peritoneal dialysis", 
            "peritonitis"
        ], 
        "lastchanged_date": "February 6, 2013", 
        "location": {
            "contact": {
                "email": "nsaiprasertkit@gmail.com", 
                "last_name": "Nalinee Saiprasertkit, MD.", 
                "phone": "66865899700"
            }, 
            "facility": {
                "address": {
                    "city": "Bangkok", 
                    "country": "Thailand", 
                    "zip": "10330"
                }, 
                "name": "Chulalongkorn university"
            }, 
            "investigator": [
                {
                    "last_name": "Nalinee Saiprasertkit, MD.", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "Worapot Treamtrakanpon, MD.", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Recruiting"
        }, 
        "location_countries": {
            "country": "Thailand"
        }, 
        "number_of_arms": "4", 
        "official_title": "Single Versus Combined Antibiotic Therapy for Bacterial Peritonitis in Continuous Ambulatory Peritoneal Dialysis Patients", 
        "overall_contact": {
            "email": "golfnephro@hotmail.com", 
            "last_name": "Talerngsak Kanjanabuch, Assoc. Prof.", 
            "phone": "662-2564321", 
            "phone_ext": "211"
        }, 
        "overall_official": {
            "affiliation": "Chulalongkorn University", 
            "last_name": "Nalinee Saiprasertkit, MD.", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Recruiting", 
        "oversight_info": {
            "authority": "Thailand: Institutional Review Board", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2013", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "measure": "relapse or recurrent rate", 
            "safety_issue": "Yes", 
            "time_frame": "within 4 weeks after peritonitis treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01785641"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "source": "Chulalongkorn University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Chulalongkorn University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "December 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "February 2013"
    }
}